Products

Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.

Connect With Us

Immunotherapy (Bispecific Antibody) (14)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Blinatumomab	Bispecific T-Cell Engager	Both (Solid & Hematologic)
Molecule Blinatumomab Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Amivantamab	Bispecific T-Cell Engager	Both (Solid & Hematologic)
Molecule Amivantamab Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Teclistamab	Bispecific T-Cell Engager	Both (Solid & Hematologic)
Molecule Teclistamab Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Talquetamab	Bispecific T-Cell Engager	Both (Solid & Hematologic)
Molecule Talquetamab Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Elranatamab	Bispecific T-Cell Engager	Both (Solid & Hematologic)
Molecule Elranatamab Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Mosunetuzumab	Bispecific T-Cell Engager	Both (Solid & Hematologic)
Molecule Mosunetuzumab Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Epcoritamab	Bispecific T-Cell Engager	Both (Solid & Hematologic)
Molecule Epcoritamab Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Glofitamab	Bispecific T-Cell Engager	Both (Solid & Hematologic)
Molecule Glofitamab Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Odronextamab	Bispecific T-Cell Engager	Both (Solid & Hematologic)
Molecule Odronextamab Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Plamotamab	Bispecific T-Cell Engager	Both (Solid & Hematologic)
Molecule Plamotamab Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Cevostamab	Bispecific T-Cell Engager	Both (Solid & Hematologic)
Molecule Cevostamab Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Linvoseltamab	Bispecific T-Cell Engager	Both (Solid & Hematologic)
Molecule Linvoseltamab Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager

Blinatumomab Immunotherapy (Bispecific Antibody)
Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Amivantamab Immunotherapy (Bispecific Antibody)
Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Teclistamab Immunotherapy (Bispecific Antibody)
Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Talquetamab Immunotherapy (Bispecific Antibody)
Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Elranatamab Immunotherapy (Bispecific Antibody)
Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Mosunetuzumab Immunotherapy (Bispecific Antibody)
Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Epcoritamab Immunotherapy (Bispecific Antibody)
Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Glofitamab Immunotherapy (Bispecific Antibody)
Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Odronextamab Immunotherapy (Bispecific Antibody)
Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Plamotamab Immunotherapy (Bispecific Antibody)
Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Cevostamab Immunotherapy (Bispecific Antibody)
Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager
Linvoseltamab Immunotherapy (Bispecific Antibody)
Therapeutic Category Immunotherapy (Bispecific Antibody) Oncology Type Both (Solid & Hematologic) Drug Class / Mechanism Bispecific T-Cell Engager

‹ 1 2 ›

Product Range

Company

Global Network

Products

Blinatumomab

Amivantamab

Teclistamab

Talquetamab

Elranatamab

Mosunetuzumab

Epcoritamab

Glofitamab

Odronextamab

Plamotamab

Cevostamab

Linvoseltamab